Controlled Clinical TrialiVNS

Direct vagus nerve stimulation: A new tool to control allergic airway inflammation through α7 nicotinic acetylcholine receptor

Sévoz‐Couche C, Liao W, Foo HYC, Bonne I, Lu TB, Tan Qi Hui C, Azhar SH, Peh WYX, Yen S, Wong WSF

British Journal of Pharmacology · 2024

Key finding

Yet, the effects of vagus nerve stimulation (VNS)-induced CAP on allergic inflammation remain unknown.

Condition
Inflammation
Stimulation
iVNS
Evidence tier
Controlled Clinical Trial
Participants
View on DOI

Cite this study

Sévoz‐Couche, C., Liao, W., Foo, H. Y. C., Bonne, I., Lu, T. B., Tan Qi Hui, C., Azhar, S. H., Peh, W. Y. X., Yen, S., & Wong, W. S. F. (2024). Direct vagus nerve stimulation: A new tool to control allergic airway inflammation through α7 nicotinic acetylcholine receptor. British Journal of Pharmacology, 181(13), 1916-1934. https://doi.org/10.1111/bph.16334

Related studies in Inflammation

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.